Inovio Pharmaceuticals, Inc.
Updated

Note to INO

196
Watch for funding or manufacturing expansion, phase 1 data should not have big impacts to sp.
Other vx ahead may also down play ino,
If down or bad attack, sell first then ask why.
Trade closed: target reached

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.